Search Results
Baxter Recognized as a Best Employer in the Asia Pacific Region by Aon
Baxter International Inc. (Baxter), a leading global medical products company, today announced it has been named Aon Best Employer, Asia Pacific (APAC).
Baxter Named to Dow Jones Sustainability Index for 19th Consecutive Year, Recognized for its Dedication to Corporate Responsibility
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that it has been named to the Dow Jones Sustainability World Index (DJSI World Index) and the Dow Jones Sustainability North America Index (DJSI North America) for the 19th consecutive year.
Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food and Drug Administration (FDA) clearance of Actifuse Flow Bone Graft Substitute for use in a variety of orthopedic surgical procedures.
Baxter Unveils Olimel 7.6% High Protein Nutrition Formulation at the 2018 ESPEN Congress
Baxter International Inc.
Baxter Announces CE Mark and Regulatory Approval of New Evo IQ Infusion System for the United Kingdom, Ireland, Australia and New Zealand
Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced the CE marking of the Evo IQ Infusion System. In addition to the planned marketing of the device in the United Kingdom, Ireland and New Zealand, the Evo IQ Infusion System recently received regulatory approval by the Therapeutic Goods Administration (TGA) in Australia.
Baxter Reports Second-Quarter 2018 Results and Increases Earnings Outlook for Full-Year 2018
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2018 and increased its full-year 2018 earnings guidance.
Baxter Recognized as an Inclusion and Diversity Leader
Baxter is proud to be recognized on the 2018 Diversity Best Practices (DBP) Inclusion Index of U.S.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The dividend is payable on October 1, 2018, to stockholders of record as of August 31, 2018. The indicated annual dividend rate is $0.76 per share of common stock.
Baxter to Host Second Quarter 2018 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE: BAX) will host a conference call to discuss its second quarter 2018 financial results on Thursday, July 26, 2018, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international). Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 2998733.